ICRC-Models HHCoM issues

ICRC-Models / HHCoM

Compartmental model of HIV and HPV heterosexual transmission, development of AIDS and cervical cancer, and interventions

3 stars 1 forks source link

issues

Newest

Newest Most commented Recently updated Oldest Least commented Least recently updated

Cc treatment

#126 clhchristine closed 5 months ago
0
Cc treatment

#125 clhchristine closed 1 year ago
0
Calibrate to HPV prevalence accounting for test-positivity rate

#124 carajbro opened 2 years ago
0
Screening algorithm not updated to KZN model changes

#123 carajbro opened 3 years ago
1
Results code not set up to process outputs for ages 80+

#122 carajbro opened 3 years ago
0
Decide on ART/VMMC assumptions between 2017-2020

#121 carajbro opened 3 years ago
0
Change UW simulation intervention year from 2020 to 2021

#120 carajbro opened 3 years ago
0
Rerun UW scenarios through 2122

#119 carajbro opened 3 years ago
0
Validation to Globocan 2020 data

#118 carajbro opened 3 years ago
0
Condom use scale-up years

#117 carajbro opened 3 years ago
0
Tracking cancer incidence by vaccination status

#116 guiliu53 opened 3 years ago
0
Consider adding the effect of HPV on HIV acquisition based on Gui's VOICE analysis

#115 carajbro opened 3 years ago
0
Make code for ART scale-up more flexible and robust

#114 carajbro opened 3 years ago
0
Pull nonVaxInfections branch into master

#113 carajbro closed 3 years ago
0
Less sensitive to vaccine waning than other models in WHO comparison

#112 carajbro opened 3 years ago
0
Non vax infections mod screen

#111 carajbro closed 3 years ago
0
Non vax infections vax wane

#110 carajbro closed 3 years ago
0
Should condom use vary by risk group

#109 carajbro opened 3 years ago
0
Why is HIV prevalence so different in AHRI data request and Vandormael paper before 2010?

#108 carajbro opened 3 years ago
0
List differences between Kenya and KZN model structures

#107 carajbro opened 3 years ago
2
May need to calibrate changes over time to partnerships and risk distribution

#106 carajbro opened 3 years ago
0
Check that sexual behavior priors lead to good fits

#105 carajbro opened 3 years ago
0
Check that HPV/CIN/CC age and HIV+ progression/regression multipliers still fit

#104 carajbro opened 3 years ago
1
Improve fit to CIN1, CIN2, CIN3 prevalence (Kuhn, 2015) targets

#103 carajbro opened 3 years ago
0
Improve fit to female HIV prevalence; narrow HIV prevalence credibility intervals

#102 carajbro opened 3 years ago
1
Recalibrate HPV type distribution

#101 carajbro opened 3 years ago
0
Recalibrate assuming increase HPV/CIN/CC in KZN

#100 carajbro opened 3 years ago
2
Consider "validating" cervical cancer incidence in HIV-negative individuals to Global Burden of Disease incidence data over time

#99 carajbro opened 3 years ago
0
Narrow cervical cancer incidence credibility intervals

#98 carajbro opened 3 years ago
0
Calibrate to the proportion male/female in each age category

#97 carajbro opened 4 years ago
0
We do not model reactivation of HPV infection in older women

#96 carajbro opened 4 years ago
0
Poor fit to observed HPV prevalence data for ages 17-19

#95 carajbro opened 4 years ago
0
Rethink age trends in precancer progression and regression rates

#94 carajbro opened 4 years ago
3
Adjust HIV-associated mortality for untreated and treated groups

#93 darcyrao opened 4 years ago
1
Relative duration of CIN2 compared to CIN1 and CIN3

#92 carajbro closed 4 years ago
1
Definition of a HPV coinfection

#91 carajbro closed 4 years ago
3
VMMC not set up to provide HIV-positive men protection from HPV acquisition

#90 carajbro opened 4 years ago
0
VMMC ages not compatible for running model with single age groups

#89 carajbro opened 4 years ago
0
Prior for per-act HPV transmission rate

#88 carajbro closed 4 years ago
1
Assumptions about naturally acquired immunity after HPV infection

#87 carajbro opened 4 years ago
2
Background mortality trends after 1985

#86 carajbro closed 4 years ago
2
HIV-associated mortality is too high

#85 carajbro closed 4 years ago
3
Condom use calibration range

#84 carajbro closed 4 years ago
1
Art cov limits

#83 carajbro closed 4 years ago
0
Refine baseline screening coverage and frequency

#82 carajbro closed 3 years ago
4
Should HPV clearance/regression differ by type

#81 carajbro opened 4 years ago
0
ART scale-up trend assumption

#80 carajbro opened 4 years ago
0
Male HPV prevalence consistently too high

#79 carajbro closed 4 years ago
4
Have a proportion of women that never get screened

#78 carajbro opened 4 years ago
1
Rethink HPV states on a molecular level

#77 carajbro opened 4 years ago
0